Buruli ulcer

Precise incidence is unknown. It is the 3rd human mycobacterial disease in importance after tuberculosis and leprosy. It is possible that ethnic endogamy is a promoting factor. This endemic infectious disease is caused by an atypical Mycobacteria, mycobacterium ulcerans, that produces a lipid exotoxin that destroys tissue and decreases immunity. The disease occurs mainly in marshy areas in humid tropical regions (Africa, Asia, South America).


Epidemiology: high (red), moderate (yellow) or low (green) endemicity. (*) isolated cases


The infection arises either by direct contact (skin breakdown) or by the bite of a vector such as the water bug Naucoris cimicoid.

Three evolutionary stages are described:

1: non-ulcerated lesion:

2: ulcerated lesion: more or less extensive, painless, yellowish background and detached edges

3: scarring lesions: atrophic scars; sometimes periarticular flanges.



Single lesion, multifocal and osteoarticular forms can be encountered. The lesions may present at different clinical stages.

Treatments:

-        local care of the necrotic lesions: painless, rarely requiring anesthesia

-        medical treatment: rifampicin, oxoflacine with or without subcutaneous heparin

-        surgical treatment: resection of nodules, excision of necrotic areas with delayed skin graft, surgical repair of the periarticular flanges


Anesthetic implications:

malnutrition and anemia due to chronic infection


References : 

-        Casanova J.L.
Mendelian predisposition to mycobacterial infections in humans.
J Soc. Biol 2000; 194 : 25-8.

-        Lehman L,  Simonet  V, Saunderson  P,  Agbenorku P .
Ulcère de Buruli.
OMS 20016

-        Kouame K, Kacou DE, Kanga JM.
Lulcère de Buruli chez lenfant.
In Les plaies de lenfant, éditeurs: R Vanwijck et L Forest-Lalande, Sauramps, 2009: 201-11.


Updated: January 2018